日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Return to intended oncological therapy following advanced ovarian cancer surgery: a narrative review

晚期卵巢癌手术后恢复原计划肿瘤治疗：一项叙述性综述

期刊:Anaesthesia
影响因子:6.9
doi:10.1111/anae.16521
Tse, Ka Yu; Chu, Mandy Man Yee; Chiu, Jessie Wan Kam; Kwok, Shuk Tak; Irwin, Michael G; Chan, Aaron Hey Yin; Ho, Polly; Cheng, Calvin Pak Wing; Ngu, Siew Fei; Chan, Karen Kar Loen
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Prospective validation of the role of PET/CT in detecting disease after neoadjuvant chemotherapy in advanced ovarian cancer

前瞻性验证PET/CT在晚期卵巢癌新辅助化疗后疾病检测中的作用

期刊:European Radiology
影响因子:4.7
doi:10.1007/s00330-024-10674-y
Lee, Elaine Yuen Phin; Ip, Philip Pun Ching; Tse, Ka Yu; Chiu, Keith Wan Hang; Chu, Mandy Man Yee; Chai, Yu Ka; Wu, Philip Yuguang; Law, Jessica Yun Pui; Kwok, Shuk Tak; Chiu, Wan Kam; Ngan, Hextan Yuen Sheung
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

The Value of Four-Quadrant Cervical Biopsy in Women with Different Colposcopic Impressions

四象限宫颈活检对不同阴道镜检查结果女性的价值

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics13142384
Chu, Mandy Man-Yee; Cheung, Charleen Sze-Yan; Ngu, Siew-Fei; Tse, Ka-Yu; Ip, Philip Pun-Ching; Cheung, Annie Nga-Yin; Ngan, Hextan Yuen-Sheung; Chan, Karen Kar-Loen
发表日期：2023
文献求助 收藏

Tamoxifen use in recurrent ovarian cancer in a Chinese population: A 15 -year clinical experience in a tertiary referral center

他莫昔芬在中国复发性卵巢癌患者中的应用：一家三级转诊中心15年的临床经验

期刊:Asia-Pacific Journal of Clinical Oncology
影响因子:1.6
doi:10.1111/ajco.13478
Chan, Karen Kar Loen; Ngu, Siew Fei; Chu, Mandy Man Yee; Tse, Ka Yu; Ngan, Hextan Yuen Sheung
肿瘤
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

Differentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value

利用最大标准化摄取值区分子宫肉瘤的侵袭性和惰性亚型

期刊:Nuclear Medicine Communications
影响因子:1.3
doi:10.1097/MNM.0000000000000005
Lee, Elaine Yuen Phin; Khong, Pek-Lan; Tse, Ka Yu; Chan, Karen Kar Loen; Chu, Mandy Man Yee; Ngan, Hextan Yuen Sheung
发表日期：2013
文献求助 收藏